The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study

The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study

Bibliografiset tiedot
Päätekijät:	Thornhill, J, Herrera, C, Hoare, J, Peake, S, Brown, H, Nwokolo, N, Fox, J, Hanke, T, Frater, J, Fidler, S
Aineistotyyppi:	Conference item
Kieli:	English
Julkaistu:	Wiley 2019

Samankaltaisia teoksia

Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection
Tekijä: Thornhill, JP, et al.
Julkaistu: (2019)

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
Tekijä: Thornhill, J, et al.
Julkaistu: (2019)

Advancing the HIV cure agenda: the next 5 years.
Tekijä: Thornhill, J, et al.
Julkaistu: (2015)

CD32-expressing CD4 T cells are phenotypically diverse and can contain proviral HIV DNA
Tekijä: Martin, G, et al.
Julkaistu: (2018)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery.
Tekijä: Thornhill, J, et al.
Julkaistu: (2017)

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
Tekijä: Matthew Pace, et al.
Julkaistu: (2022-08-01)

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
Tekijä: Frater, J, et al.
Julkaistu: (2019)

Vorinostat-An overview
Tekijä: Aditya Kumar Bubna
Julkaistu: (2015-01-01)

OA1-2 Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
Tekijä: G.E. Martin, et al.
Julkaistu: (2017-07-01)

Enrichment of the HIV reservoir in CD32+CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
Tekijä: Martin, GE, et al.
Julkaistu: (2017)

Persistent elevation of Tim-3 and PD-1 on memory T cells despite early ART initiation during primary HIV infection
Tekijä: G.E. Martin, et al.
Julkaistu: (2019-07-01)

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
Tekijä: Genevieve E. Martin, et al.
Julkaistu: (2018-05-01)

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.
Tekijä: Julian H Elliott, et al.
Julkaistu: (2014-10-01)

Lack of effect of Maraviroc intensification on blood and gut reservoir.
Tekijä: Tiraboschi, J, et al.
Julkaistu: (2016)

The role of the gut mucosa in protection from HIV-1 in highly exposed persistently seronegative individuals (HEPS)
Tekijä: Fox, J, et al.
Julkaistu: (2009)

Levels of human immunodeficiency virus DNA are determined before art initiation and linked to CD8 T-cell activation and memory expansion
Tekijä: Martin, GE, et al.
Julkaistu: (2019)

Vorinostat in solid and hematologic malignancies
Tekijä: Richon Victoria M, et al.
Julkaistu: (2009-07-01)

Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment
Tekijä: White, C, et al.
Julkaistu: (2018)

Immunotherapeutic approaches to HIV cure and remission
Tekijä: Lee, MJ, et al.
Julkaistu: (2021)

Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection
Tekijä: Fidler, S, et al.
Julkaistu: (2017)

The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection
Tekijä: C. Gay, et al.
Julkaistu: (2019-07-01)

Antioxidants impair anti-tumoral effects of Vorinostat, but not anti-neoplastic effects of Vorinostat and caspase-8 downregulation.
Tekijä: Laura Bergadà, et al.
Julkaistu: (2014-01-01)

Vorinostat enhances the therapeutic potential of Erlotinib via MAPK in lung cancer cells
Tekijä: Amany I Alqosaibi, et al.
Julkaistu: (2022-01-01)

HIV-1 drug resistance in primary infections in the UK.
Tekijä: Fidler, S, et al.
Julkaistu: (2001)

OA1-1 Impact of vorinostat treatment of non-Hodgkin‘s lymphoma on HIV-1 latent reservoir
Tekijä: A. Capoferri, et al.
Julkaistu: (2017-07-01)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
Tekijä: Foster, C, et al.
Julkaistu: (2017)

Vorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cells.
Tekijä: Luca A Petruccelli, et al.
Julkaistu: (2011-01-01)

The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut
Tekijä: Kevin Brown, et al.
Julkaistu: (2024-09-01)

A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study
Tekijä: Fidler, S, et al.
Julkaistu: (2017)

The effect of vorinostat on the development of resistance to doxorubicin in neuroblastoma.
Tekijä: Timothy B Lautz, et al.
Julkaistu: (2012-01-01)

Clinical Efficacy of Vorinostat in a Patient with Leiomyosarcoma
Tekijä: Jin Lee, et al.
Julkaistu: (2012-02-01)

Clinical Efficacy of Vorinostat in a Patient with Leiomyosarcoma
Tekijä: Jin Lee, et al.
Julkaistu: (2012-01-01)

PP 3.10 – 00168 Vpr synergizes with vorinostat to prevent HIV-1 latency establishment
Tekijä: C. Lewis, et al.
Julkaistu: (2022-12-01)

HIV's gut feeling.
Tekijä: Sattentau, Q
Julkaistu: (2008)

Activation of the Unfolded Protein Response Contributes toward the Antitumor Activity of Vorinostat
Tekijä: Soumen Kahali, et al.
Julkaistu: (2010-01-01)

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
Tekijä: Eugène D.M.B. Kroon, et al.
Julkaistu: (2020-09-01)

Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat
Tekijä: Nasreddine El Omari, et al.
Julkaistu: (2024-06-01)

Direct but no transgenerational effects of decitabine and vorinostat on male fertility.
Tekijä: Ruth Kläver, et al.
Julkaistu: (2015-01-01)

Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
Tekijä: Hoffmann, M, et al.
Julkaistu: (2016)

Gut mucosa in HIV infection: "immune milk" solution.
Tekijä: Shawn J Green
Julkaistu: (2007-02-01)